Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | NOS3 | P29474 | 1/20 | 0.30 |
| ▸ | NOS1 | P29475 | 1/20 | 0.30 |
| ▸ | NOS2 | P35228 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4087492 | 0.76 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL14543886 | 0.75 | CA12 (0.31) | — | |
| SCHEMBL10905067 | 0.75 | CA1 (0.34) | — | |
| SCHEMBL19401 | 0.75 | CA1 (0.34) | — | |
| SCHEMBL18891261 | 0.74 | SCN9A (0.46) | MAPT | |
| Water SCHEMBL9507408 | 0.73 | CA1 (0.33) | — | |
| Hydroxyamine SCHEMBL11315924 | 0.71 | CA1 (0.32) | — | |
| SCHEMBL11853374 | 0.71 | S1PR2 (0.35) | ALDH1A1 | |
| SCHEMBL10996792 | 0.71 | ALDH1A1 (0.49) | MAPTALDH1A1 | |
| Formaldehyde SCHEMBL3043572 | 0.71 | CA1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3359575-B1 | ANTIBODIES SPECIFIC FOR 4,6-DIAMINO-5-(FORMYLAMINO) PYRIMIDINE AND USES THEREOF | UNIV FLORIDA STATE RES FOUND (US) | 2020-07-22 | — | — | EP | disclosed |
| US-10562978-B2 | Methods using antibodies specific for 4,6-diamino-5-(formamido)pyrimidine | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2020-02-18 | — | — | US | disclosed |
| US-20180066071-A1 | METHODS USING ANTIBODIES SPECIFIC FOR 4,6-DIAMINO-5-(FORMAMIDO)PYRIMIDINE | UNIV FLORIDA STATE RES FOUND (US) | 2018-03-08 | — | — | US | disclosed |
| US-9884920-B2 | Antibodies specific for 4,6-diamino-5-(formamido)pyrimidine and uses thereof | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2018-02-06 | — | — | US | disclosed |
| US-20170101481-A1 | ANTIBODIES SPECIFIC FOR 4,6-DIAMINO-5-(FORMYLAMINO)PYRIMIDINE AND USES THEREOF | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2017-04-13 | — | — | US | disclosed |
| WO-2017062966-A1 | ANTIBODIES SPECIFIC FOR 4,6-DIAMINO-5-(FORMYULAMINO) PYRIMIDINE AND USES THEREOF | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2017-04-13 | — | — | WO | disclosed |
| EP-1957057-A1 | STRUCTURAL CAROTENOID ANALOGS OR DERIVATIVES FOR THE MODULATION OF SYSTEMIC AND/OR TARGET ORGAN REDOX STATUS | Cardax Pharmaceuticals, Inc. (US) | 2008-08-20 | — | — | EP | disclosed |
| US-20070238793-A1 | Structural carotenoid analogs or derivatives for the modulation of systemic and/or target organ redox status | CARDAX PHARMACEUTICALS, INC. | 2007-10-11 | — | — | US | disclosed |
| WO-2007067957-A1 | STRUCTURAL CAROTENOID ANALOGS OR DERIVATIVES FOR THE MODULATION OF SYSTEMIC AND/OR TARGET ORGAN REDOX STATUS | CARDAX PHARMACEUTICALS, INC. (US) | 2007-06-14 | — | — | WO | disclosed |
| US-20050215529-A1 | Method of treating oxidative stress-associated conditions with isopentenyl diphosphate | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2005-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238793-A1 | Structural carotenoid analogs or derivatives for the modulation of systemic and/or target organ redox status | LPO, TXN2, TXNRD2 | MAPT 3121/4885TDP1 1541/4885CYP3A4 267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.